Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00524394 · ClinicalTrials.gov registry record
Characteristics of Cord Blood Immunologic Parameters of Infants <32 Weeks Gestation
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- 2
- Enrollment target
NCT00524394 is a clinical trial that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 2 participants.
The verdict
NCT00524394 was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
Infants in the NICU are at high risk for morbidity and mortality from infections of any onset. Diagnosis of these infections is imperfect at best. Patterns of inflammatory and regulatory proteins (cytokines \& chemokines, in addition to antigen detection on antibody secreting cells (ASC's)may provide a more accurate and rapid approach to diagnosis of infections in these high-risk patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2007-08 |
| Est. Completion | 2012-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00524394
The ClinicalTrials.gov registry entry for NCT00524394 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00524394 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00524394 about?
NCT00524394 is a clinical study titled "Characteristics of Cord Blood Immunologic Parameters of Infants <32 Weeks Gestation". Infants in the NICU are at high risk for morbidity and mortality from infections of any onset. Diagnosis of these infections is imperfect at best. Patterns of inflammatory and regulatory proteins (cytokines \& chemokines, in addition to antigen detection on antibody secreting cells (ASC's)may provid...
What is the current status of trial NCT00524394?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2007-08. Estimated completion is 2012-01.
Who is sponsoring clinical trial NCT00524394?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.